Guoran2018-03-17 22:03
$Neovasc Inc.(NVCN)$ 医疗器械公司,导管技术治疗二尖瓣疾病和心绞痛。17年11月,FDA批准了后一项的临床实验。产品尚未在美国开始销售。公司目前最大问题是17年11月13日,地方法庭判决其赔偿CardiAQ1.12亿美金。公司3季度报中可以看到该项负债。公司资不抵债,缺口4200万现金。11月13日公司增发新...查看全文
$Neovasc(NVCN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-044460 Act: 34 Size: 34 KB 网页链接
$Neovasc(NVCN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-043866 Act: 34 Size: 4 MB 网页链接
$Neovasc(NVCN)$ RW Registration Withdrawal Request Accession Number: 0001104659-23-043861 Act: NE Size: 7 KB 网页链接
$Neovasc(NVCN)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-043856 Act: 33 Size: 22 KB 网页链接
$Neovasc(NVCN)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001104659-23-043857 Act: 33 Size: 25 KB 网页链接
$Neovasc(NVCN)$ F-10POS Post-effective amendment to a F-10EF registration Accession Number: 0001104659-23-043858 Act: 33 Size: 27 KB 网页链接
$Neovasc(NVCN)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-23-000260 Act: 34 Size: 2 KB 网页链接
$Neovasc(NVCN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001062993-23-008995 Act: 34 Size: 27 KB 网页链接
$Neovasc(NVCN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-040217 Act: 34 Size: 2 MB 网页链接
$Neovasc(NVCN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-030600 Act: 34 Size: 4 MB 网页链接